Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Richter, Forest Report Positive Phase III Cariprazine Result

Gedeon Richter Nyrt., Hungary’s biggest drugmaker, and Forest Laboratories Inc. reported today “positive” results from a Phase III clinical trial of cariprazine, an antipsychotic agent.

Data showed that patients with acute manic episodes who were treated with cariprazine “experienced significant symptom improvement compared with placebo-treated patients,” the two companies said in a statement posted on the website of the Budapest Stock Exchange today.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.